Published in Radiother Oncol on June 01, 2000
Same strategy for pitfalls of radiotherapy in different anatomical districts. Lasers Med Sci (2016) 1.00
Transplantation of oligodendrocyte precursor cells improves locomotion deficits in rats with spinal cord irradiation injury. PLoS One (2013) 0.93
The Impact of Clinical Stage on Radiation Doses to Organs at Risk Following Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma: A Prospective Analysis. J Cancer (2016) 0.75
A surveillance study of the current status of reirradiation and patterns of practice. J Radiat Res (2016) 0.75
Radiobiological effects of total body irradiation on the spinal cord. Radiat Environ Biophys (2009) 0.75
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys (2000) 7.50
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet (2008) 6.50
Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med (1992) 5.14
Functional analysis of cyclin-dependent kinase inhibitors of Arabidopsis. Plant Cell (2001) 4.62
Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst (2000) 4.15
Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group. J Clin Oncol (1997) 3.45
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol (2008) 3.31
Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment ... now! Int J Radiat Oncol Biol Phys (1995) 3.05
Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet (1995) 3.03
National audit of the management and outcome of carcinoma of the cervix treated with radiotherapy in 1993. Clin Oncol (R Coll Radiol) (2000) 2.95
Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys (1995) 2.50
Steepness of the dose-response curve as a function of volume in an experimental tumor irradiated under ambient or hypoxic conditions. Int J Radiat Oncol Biol Phys (1997) 2.48
Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst (2001) 2.44
New manzamine alkaloids with potent activity against infectious diseases. J Am Chem Soc (2001) 2.35
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol (1997) 2.23
Primary radiotherapy in the treatment of stage I and II oral tongue cancers: importance of the proportion of therapy delivered with interstitial therapy. Int J Radiat Oncol Biol Phys (1990) 2.07
Is it necessary to repeat quality control procedures for head and neck patients? Radiother Oncol (1991) 1.93
Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr (1992) 1.89
Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys (1993) 1.85
Appendicitis: usefulness of US in diagnosis in a pediatric population. Radiology (1992) 1.76
Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol (2001) 1.75
Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys (1997) 1.70
The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys (1995) 1.60
Effects of continuous hyperfractionated accelerated and conventionally fractionated radiotherapy on the parotid and submandibular salivary glands of rhesus monkeys. Radiother Oncol (1995) 1.58
Breast conserving treatment of Paget's disease. Radiother Oncol (1990) 1.54
Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy. Int J Radiat Oncol Biol Phys (1996) 1.53
Time-dose factors in radiotherapy: a review of the human data. Radiother Oncol (1990) 1.51
Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas. Clin Cancer Res (1999) 1.48
Is pulsed dose rate more damaging to spinal cord of rats than continuous low dose rate? Radiother Oncol (1997) 1.46
Relationship between radioligand binding assay, immunoenzyme assay and immunohistochemical assay for estrogen receptors in human breast cancer and association with tumor differentiation. Eur J Cancer Clin Oncol (1988) 1.45
Peripheral nerve regeneration: the effects of postoperative irradiation. Plast Reconstr Surg (1997) 1.42
[100 years of radiology in the Netherlands. IX. Clinical radiobiology]. Ned Tijdschr Geneeskd (1995) 1.40
Profile of radiotherapy departments contributing to the Cooperative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys (1996) 1.40
Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. 1996. Int J Hyperthermia (2009) 1.39
Dose-response relationships for late radiation effects in the head and neck: regarding the analysis of the RTOG 8313 trial, Fu et al. IJROBP 32:577-588; 1995. Int J Radiat Oncol Biol Phys (1996) 1.39
Vindesine-ifosfamide-platinum (VIP) induction chemotherapy in surgically staged IIIA-N2 non-small-cell lung cancer: a prospective study. Leuven Lung Cancer Group. Ann Oncol (1998) 1.38
Are the results of the St Thomas' trial of post-mastectomy radiotherapy inconsistent with the predictions from the linear-quadratic model? Br J Radiol (1989) 1.38
Radiation nephropathy in the rhesus monkey: morphometric analysis of glomerular and tubular alterations. Int J Radiat Oncol Biol Phys (1995) 1.37
Postoperative radiation therapy for malignant tumors of minor salivary glands. Outcome and patterns of failure. Cancer (1994) 1.35
Quality control of validity of data collected in clinical trials. EORTC Study Group on Data Management (SGDM). Eur J Cancer Clin Oncol (1989) 1.33
Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys (1997) 1.33
Cutaneous angiosarcoma of the head and neck. A therapeutic dilemma. Cancer (1995) 1.31
A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin Oncol (R Coll Radiol) (1996) 1.31
Locally advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy. An EORTC Breast Cancer Co-operative Group Trial (10792). Eur J Cancer Clin Oncol (1989) 1.30
Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases. Radiother Oncol (1998) 1.27
Interobserver variations in gross tumor volume delineation of brain tumors on computed tomography and impact of magnetic resonance imaging. Radiother Oncol (2001) 1.26
The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation. Radiother Oncol (1987) 1.26
Cosmetic evaluation of breast conserving treatment for mammary cancer. 1. Proposal of a quantitative scoring system. Radiother Oncol (1989) 1.25
Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors. J Magn Reson Imaging (2001) 1.25
Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies. Acta Oncol (1988) 1.23
Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: preliminary results of a risk-stratified phase I dose escalation study. Technol Cancer Res Treat (2008) 1.21
Prognostic variables in parotid gland cancer. Arch Otolaryngol Head Neck Surg (1991) 1.19
Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. Int J Hyperthermia (1996) 1.18
Tissue tolerance to reirradiation. Semin Radiat Oncol (2000) 1.17
Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival. Radiother Oncol (1997) 1.17
Acute and late radiation injury in rhesus monkey parotid glands. Evidence of interphase cell death. Am J Pathol (1986) 1.16
Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model. Microvasc Res (2008) 1.15
Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys (1994) 1.15
Etiology of intestinal damage in gastroschisis. I: Effects of amniotic fluid exposure and bowel constriction in a fetal lamb model. J Pediatr Surg (1989) 1.14
Reirradiation of primary brain tumours: survival, clinical response and prognostic factors. Radiother Oncol (2001) 1.14
Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma. J Clin Oncol (1998) 1.11
Enhancement of tumor radioresponse in vivo by gemcitabine. Cancer Res (1999) 1.11
Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis. Int J Radiat Oncol Biol Phys (2000) 1.11
Precisely defining high-risk operable head and neck tumors based on RTOG #85-03 and #88-24: targets for postoperative radiochemotherapy? Head Neck (1998) 1.10
A real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) to detect breast carcinoma cells in peripheral blood. Ann Oncol (2001) 1.09
A "reappraisal" of the LQ model for the understanding of dose-fractionation in radiotherapy. Int J Radiat Oncol Biol Phys (1993) 1.09
Late effects of spinal cord irradiation with 300 kV X rays and 15 MeV neutrons. Br J Radiol (1974) 1.07
Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother Oncol (1996) 1.07
Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts. Microvasc Res (1995) 1.05
Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. Int J Radiat Biol (1993) 1.05
Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results. Radiother Oncol (1989) 1.05
C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability. Int J Radiat Oncol Biol Phys (2001) 1.05
Human errors in data transfer during the preparation and delivery of radiation treatment affecting the final result: "garbage in, garbage out". Radiother Oncol (1992) 1.04
Radiation apoptosis of serous acinar cells of salivary and lacrimal glands. Cancer (1991) 1.04
Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter- and intratumour heterogeneity. Acta Oncol (1994) 1.03
The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments. Clin Oncol (R Coll Radiol) (2007) 1.03
Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control. Radiother Oncol (1987) 1.03
Quality assessment of medical decision making in radiation oncology: variability in target volume delineation for brain tumours. Radiother Oncol (1993) 1.02
Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple? Int J Radiat Oncol Biol Phys (2001) 1.02
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study. Ann Oncol (2011) 1.02
Blunt hepatic and splenic trauma in children: correlation of a CT injury severity scale with clinical outcome. Pediatr Radiol (1995) 1.01
Clinical and pharmacokinetic risk factors for high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia--a logistic regression analysis. Acta Oncol (1998) 1.01
Selection of active drugs for ovarian cancer based on CA-125 and standard response rates in phase II trials. J Clin Oncol (2000) 1.01
The significance of perineural spread in adenoid cystic carcinoma of the major and minor salivary glands. Int J Oral Maxillofac Surg (1988) 1.01
Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation. Br J Cancer (2002) 1.00
Acute reactions of the lip mucosa of mice to fractionated irradiations. Radiother Oncol (1984) 1.00
The essential role of radiation therapy in securing locoregional control of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys (1990) 0.99
Vascularity and perfusion of human gliomas xenografted in the athymic nude mouse. Br J Cancer (1995) 0.99
Effects of nicotinamide and carbogen on oxygenation in human tumor xenografts measured with luminescense based fiber-optic probes. Radiother Oncol (2000) 0.99
Target cell and mode of radiation injury in rhesus salivary glands. Radiother Oncol (1986) 0.99
Hypoxia in a human intracerebral glioma model. J Neurosurg (2000) 0.99